NCT05656547 is a clinical trial in Brain Surgery, sponsored by National Taiwan University Hospital.

Who is sponsoring NCT05656547?

NCT05656547 is sponsored by National Taiwan University Hospital.

What condition does NCT05656547 study?

NCT05656547 studies Brain Surgery.

Is NCT05656547 still recruiting?

NCT05656547 is currently status unknown. Last updated 21 December 2022.

Last reviewed 2022-12-21 · How we verify

NCT05656547

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

EEG DSA-guided Intravenous Anesthesia Using Dexmedetomidine and Propofol

Status unknown Last updated 21 December 2022

What this trial tests

trial in Brain Surgery in 140 participants. Status unknown.

Timeline

12 December 2022

Primary endpoint
25 January 2023

25 February 2023

Quick facts

Lead sponsor	National Taiwan University Hospital
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	140
Start date	12 December 2022
Primary completion	25 January 2023
Estimated completion	25 February 2023
Sites	1 location across Taiwan

Conditions studied

Brain Surgery — all drugs for Brain Surgery →

Sponsor

National Taiwan University Hospital

Who can join

Adults 20 to 80, any sex, with Brain Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Investigators conduct this retrospective analysis to test this hypothesis that the EEG spectrogram guided general anesthesia with dexmedetomidine co-administration with propofol may significantly reduce the propofol consumption during craniotomy and to investigate potential benefits on postoperative outcomes.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Electroencephalographic spectrogram-guided total intravenous anesthesia using dexmedetomidine and propofol prevents unnecessary anesthetic dosing during craniotomy: a propensity score-matched analysis.
Lin FS, Shih PY, Sung CH, Chou WH, et al · · 2024 · cited 2× · PMID 37211766 · DOI 10.4097/kja.23118

Verify or expand the search:

Other National Taiwan University Hospital trials

Trials by the same sponsor.

NCT06936917 — Timing for Computed Tomography and Post-Resuscitation Care on Short-Term Outcomes in Out-of-Hospital Cardiac Arrest · not yet recruiting
NCT05396222 — A Prospective Study of the Safety and Efficacy of 3D-printed Non-rigid Biomimetic Implant in Cervical and Thoracolumbar · NA · not yet recruiting
NCT07532356 — Integrating Tumor Genomics and Urinary Exosomal Proteomics to Establish a Multi-Layer Biomarker Framework for Early Risk · not yet recruiting
NCT07317310 — The NTU JO-SMART Study · NA · not yet recruiting
NCT07382024 — Tirzepatide to Reduce rEcurrence And Burden After Ablation of Atrial Fibrillation · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05656547 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by National Taiwan University Hospital
Last refreshed: 21 December 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05656547.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing